{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:07:37Z","timestamp":1762916857779},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.jneuroim.2003.08.043","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T16:33:14Z","timestamp":1067358794000},"page":"143-147","source":"Crossref","is-referenced-by-count":22,"title":["Association of the Fc\u03b3 receptor IIA-R\/R131 genotype with myasthenia gravis in Dutch patients"],"prefix":"10.1016","volume":"144","author":[{"given":"W-L.","family":"van der Pol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.M.","family":"Kuks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Baets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.G.J.","family":"Leppers-van de Straat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.J.","family":"Wokke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.J.","family":"van de Winkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2003.08.043_BIB1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.44.3_Part_1.551","article-title":"Familial autoimmune myasthenia gravis","volume":"44","author":"Bergoffen","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB2","first-page":"624","article-title":"Role of the neutrophil Fc\u03b3 RIIa (CD32) and the Fc\u03b3 RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes","volume":"83","author":"Bredius","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood.V92.5.1526","article-title":"Heparin-induced thrombocytopenia: new insights into the impact of the Fc\u03b3RIIa-131R-H polymorphism","volume":"92","author":"Carlsson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1084\/jem.189.1.179","article-title":"Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors","volume":"189","author":"Clynes","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-510X(02)00200-9","article-title":"The role of antibodies in myasthenia gravis","volume":"202","author":"De Baets","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB7","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.V86.6.2403.bloodjournal8662403","article-title":"Neutrophil Fc\u03b3RIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families","volume":"86","author":"De Haas","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1529-0131(199909)42:9<1823::AID-ANR5>3.0.CO;2-X","article-title":"Fc\u03b3 receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse","volume":"42","author":"Dijstelbloem","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB9","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6","article-title":"Fc\u03b3 receptor polymorphisms in systemic lupus erythematosus. Association with disease and in vivo clearance of immune complexes","volume":"43","author":"Dijstelbloem","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(94)90084-1","article-title":"Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis","volume":"51","author":"Dondi","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB11","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/art.1780381217","article-title":"Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients","volume":"39","author":"Duits","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-119-7_Part_1-199310010-00026","article-title":"Polymorphism of IgG Fc receptors in meningococcal disease","volume":"119","author":"Fijen","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB13","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1073\/pnas.91.11.4668","article-title":"Involvement of human muscle acetylcholine receptor \u03b1-subunit gene (CHRNA) in susceptibility to myasthenia gravis","volume":"91","author":"Garchon","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-5728(96)00008-2","article-title":"Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis","volume":"65","author":"Hjelmstr\u00f6m","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-5728(98)00107-6","article-title":"Polymorphism in tumor necrosis factor genes associated with myasthenia gravis","volume":"88","author":"Hjelmstr\u00f6m","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-5728(98)00119-2","article-title":"Genetic association of Ctla-4 to myasthenia gravis with thymoma","volume":"88","author":"Huang","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(97)00161-6","article-title":"Polymorphisms in IL-1\u03b2 and IL-1 receptor antagonist genes are associated with myasthenia gravis","volume":"81","author":"Huang","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-5728(99)00140-X","article-title":"Polymorphisms at \u2212174 and in the 3\u2032 flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis","volume":"101","author":"Huang","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.V75.1.213.213","article-title":"Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc\u03b3 receptor III (CD16)","volume":"75","author":"Huizinga","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/art.10306","article-title":"Role of Fc\u03b3 receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis","volume":"46","author":"Karassa","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc\u03b3RIIIa-158V\/F polymorphism influences the binding of IgG by NK cell Fc\u03b3RIIIa, independently of the Fc\u03b3 RIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-1759(00)00240-4","article-title":"A novel PCR-based method for direct Fc\u03b3 Receptor IIIA (CD16) allotyping","volume":"242","author":"Leppers-van de Straat","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.43.3_Part_1.583","article-title":"Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation","volume":"43","author":"Melms","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00019052-199606000-00014","article-title":"The immunopathogenic role of complement in human muscle disease","volume":"9","author":"Mendell","year":"1996","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.36.1.78","article-title":"Myasthenia gravis in identical twins","volume":"36","author":"Murphy","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI116022","article-title":"On the interaction of IgG subclasses with low affinity Fc\u03b3RIIa (CD32) on human monocytes, neutrophils and platelets; analysis of functional polymorphism to human IgG2","volume":"90","author":"Parren","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(97)00174-4","article-title":"Fc\u03b3RIIa and Fc\u03b3RIIIb polymorphisms in myasthenia gravis","volume":"81","author":"Raknes","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1086\/314603","article-title":"Crucial role of Fc\u03b3RIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera","volume":"179","author":"Rodriguez","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1172\/JCI115712","article-title":"Allelic polymorphisms of human Fc\u03b3 receptor IIa and Fc\u03b3 receptor IIIb. Independent mechanisms for differences in human phagocyte function","volume":"89","author":"Salmon","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI118552","article-title":"Fc\u03b3RIIa alleles are heritable risk factors for lupus nephritis in African Americans","volume":"97","author":"Salmon","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB33","series-title":"The Immunoglobulin Receptors and Their Physiological and Pathological Roles in Immunity","first-page":"169","article-title":"Fc\u03b3R on T cells","author":"Sandor","year":"1998"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.56.12.744","article-title":"Fc\u03b3RIIa polymorphism in systemic lupus erythematosus","volume":"56","author":"Smyth","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-5699(98)01395-4","article-title":"Immune cell signaling defects in lupus: activation, anergy and death","volume":"20","author":"Tsokos","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002510050426","article-title":"IgG receptor polymorphisms: risk factors for disease","volume":"48","author":"Van der Pol","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1086\/324662","article-title":"Relevance of Fc\u03b3R and IL-10 polymorphisms for meningococcal disease","volume":"184","author":"Van der Pol","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Timeline: unravelling the pathogenesis of myasthenia gravis","volume":"10","author":"Vincent","year":"2002","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB39","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.172.1.19","article-title":"Molecular basis for a polymorphism of human Fc\u03b3 receptor II (CD32)","volume":"172","author":"Warmerdam","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.147.4.1338","article-title":"A single amino acid in the second Ig-like domain of the human Fc\u03b3 receptor II is critical for human IgG2 binding","volume":"147","author":"Warmerdam","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2003.08.043_BIB42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI119616","article-title":"A novel polymorphism of Fc\u03b3 RIIIa (CD16) alters receptor function and predisposes to autoimmune disease","volume":"100","author":"Wu","year":"1997","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:47:17Z","timestamp":1682585237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572803003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0165572803003588"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2003.08.043","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}